West Pharmaceutical Services Inc (NYSE:WST) Share Price

Company Profile

Business description
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
Contact
530 Herman O. West Drive
ExtonPA19341-1147
USA
T: +1 610 594-2900
E: John.Sweeney@westpharma.com
https://www.westpharma.com
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
31 December 2026
Employees
10,800

Recommended

These undervalued stocks with economic moats have increased their dividends for 25 consecutive years or more.

Susan Dziubinski | 27 January 2026

These undervalued stocks with wide and narrow moats have increased their dividends for 25 consecutive years or more.

Susan Dziubinski | 30 July 2025

Undervalued high-quality names from the Morningstar Wide Moat Focus Index are attractive stocks to buy for long-term investors.

Susan Dziubinski | 26 June 2025

Index	Last price	Change	% Change
All Ordinaries	8,712.80	44.30	0.51%
CAC 40	7,681.82	87.49	-1.13%
DAX 40	22,236.77	376.20	-1.66%
Dow JONES (US)	45,960.11	469.38	-1.01%
FTSE 100	9,890.67	81.50	-0.82%
HKSE	24,951.88	95.45	0.38%
NASDAQ	21,408.08	521.74	-2.38%
Nikkei 225	53,373.07	230.58	-0.43%
NZX 50 Index	12,935.39	41.60	-0.32%
S&P 500	6,477.16	114.74	-1.74%
S&P/ASX 200	8,516.30	44.70	0.53%
SSE Composite Index	3,913.72	24.64	0.63%